相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 英文名:
UM-UC-3
- 库存:
1x10^6/瓶
- 供应商:
上海酶研
- 肿瘤类型:
膀胱移行细胞癌
- 细胞类型:
UM-UC-3
- 品系:
UM-UC-3
- 组织来源:
人膀胱移行细胞癌细胞
- 相关疾病:
详询
- 物种来源:
人
- 免疫类型:
详询
- 细胞形态:
贴壁/悬浮
- 是否是肿瘤细胞:
是
- 器官来源:
人膀胱移行细胞癌细胞
- 运输方式:
顺丰快递
- 年限:
5年
- 生长状态:
生长良好
UM-UC-3、UM-UC-3、UM-UC-3细胞、UM-UC-3细胞、UM-UC-3人膀胱移行细胞癌细胞
Cell line name UM-UC-3
Synonyms UMUC-3; UM-UC3; UMUC3; UC-3; University of Michigan-Urothelial Carcinoma-3
Accession CVCL_1783
Resource Identification Initiative To cite this cell line use: UM-UC-3 (RRID:CVCL_1783)
Comments Part of: BLA-40 bladder carcinoma cell line panel.
Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
Part of: UBC-40 urothelial bladder cancer cell line index.
Population: Caucasian.
Doubling time: 24 hours (PubMed=3761468).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: CNV analysis.
Omics: Deep exome analysis.
Omics: Deep quantitative proteome analysis.
Omics: DNA methylation analysis.
Omics: GPI-anchored proteins analysis by proteomics.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Omics: Transcriptome analysis by RNAseq.
Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
PubMed=12068308; DOI=10.1038/nature00766
Davies H.R., Bignell G.R., Cox C., Stephens P.J., Edkins S., Clegg S., Teague J.W., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C.S., Shipley J.M., Hargrave D., Pritchard-Jones K., Maitland N.J., Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A., Flanagan A.M., Nicholson A., Ho J.W.C., Leung S.Y., Yuen S.T., Weber B.L., Seigler H.F., Darrow T.L., Paterson H.F., Marais R., Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.
Mutations of the BRAF gene in human cancer.
Nature 417:949-954(2002)
PubMed=12127398; DOI=10.1016/S0165-4608(01)00648-3
Strefford J.C., Lillington D.M., Steggall M., Lane T.M., Nouri A.M.E., Young B.D., Oliver R.T.D.
Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization.
Cancer Genet. Cytogenet. 135:139-146(2002)
PubMed=15846775; DOI=10.1002/gcc.20166
Williams S.V., Adams J., Coulter J., Summersgill B.M., Shipley J.M., Knowles M.A.
Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.
Genes Chromosomes Cancer 43:315-328(2005)
PubMed=16469639; DOI=10.1016/S0022-5347(05)00323-X
Sabichi A.L., Keyhani A., Tanaka N., Delacerda J., Lee I.-L., Zou C.-P., Zhou J.-H., Benedict W.F., Grossman H.B.
Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression.
J. Urol. 175:1133-1137(2006)
PubMed=18812553; DOI=10.1093/jnci/djn304; PMCID=PMC2720731
Park H.-S., Park W.S., Bondaruk J., Tanaka N., Katayama H., Lee S., Spiess P.E., Steinberg J.R., Wang Z., Katz R.L., Dinney C.P.N., Elias K.J., Lotan Y., Naeem R.C., Baggerly K., Sen S., Grossman H.B., Czerniak B.
Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
J. Natl. Cancer Inst. 100:1401-1411(2008)
PubMed=19375735; DOI=10.1016/j.juro.2009.01.108; PMCID=PMC2680455
Chiong E., Dadbin A., Harris L.D., Sabichi A.L., Grossman H.B.
The use of short tandem repeat profiling to characterize human bladder cancer cell lines.
J. Urol. 181:2737-2748(2009)
PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113
Bignell G.R., Greenman C.D., Davies H.R., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)
PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验*发表【中文论文】请标注:由上海酶研生物科技有限公司提供;
*发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.
【求助】文献上细胞给药剂量用10um是10um/ml还是10um/L啊?
haohuaiyong 大家好啊,我现在想用AG490处理细胞,干扰JAK-STAT3信号通路,查了相关文献,有的给药10Um,但是不知道(呵呵,我比较菜),是10um/ml还是10um/L,还请战友帮忙解答一下。 付文献截图 xdb86 人家的m是大写的M,M就是mol/L,10uM就是10×10-6mol/L。uM已经是一个浓度单位了,所以没有你说的:是10um/ml还是10um/L。
文献中常用的分离外泌体的方法主要是超离法和试剂盒法,那这两种方法研究人员该如何选择呢?为了解决大家的疑惑,我们专门做了对比实验进行阐述。 四、超速离心法与试剂盒法比较 (一)实验分组和开展实验确定: 此实验共分为 3 组,每组设置 2 个重复,所选原始样本是 293T 细胞培养上清。 组1:超离法分离(UC-1,UC-2); 组2:使用某国外试剂盒 SXX(SXX-1,SXX-2); 组3:使用某国内试剂盒 UXX(UXX-1,UXX-2)。 开展
几率非常大。二、进行显微镜下观察(通常观察前需先静置细胞1-2h)显微镜下可以清晰观察到细胞是否有菌类污染,菌类污染通常分为杆菌、球菌和霉菌,为了方便大家分辨,我特地找了之前收到有典型污染的细胞照片,希望能帮助大家判断。1. 杆菌常见的有大肠杆菌,长度通常在2-5um左右。2. 球菌常见的有葡萄球菌,直径通常在1-2um左右。3. 霉菌常见的有毛霉,菌丝宽2-10um左右,长度短则几十um,长则可达几mm。 需要提醒的是,因为运输过程中细胞离开了其正常生长所需要的环境,部分细胞会出现
技术资料







